Development and Efficacy Evaluation of Integrated Chronic Care and Health Promotion Model for Patients With Coronary Artery Disease in Taiwan

Not Applicable

• Conditions: Acute Myocardial Infarction; Stable Angina
• Interventions: Other: Traditional group; Behavioral: Integrated health care team

• Registration Number: NCT01357096
• Lead Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital

Brief Summary

The hypothesis of this project is to examine whether the integrated health care program as the intervention group can reduce the recurrence and mortality of coronary artery-related diseases than the traditional one as the comparison group.

Detailed Description

Not available

Study Timeline

• Status Verified: 2010-07
• Study Start: 2011-01
• Study First Submitted: 2011-05-18
• Study First Submitted QC: 2011-05-19
• Last Update Submitted: 2011-05-19
• Study First Posted: 2011-05-20
• Last Update Posted: 2011-05-20
• Primary Completion: 2012-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 400

Inclusion Criteria

• patients who suffered from acute myocardial infarction or stable angina with intervention (CABG or PTCA)

Exclusion Criteria

1. Age > 85 yrs old.
2. Worse short-term prognosis (e.g.cancer, congestive heart failure NYHA IV)
3. Any systemic disease which will limit the exercise program (e.g. bed-ridden stroke)
4. Unable to participate in the trial due to any logic reasons

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Comparison group	Traditional group	-
Integrated health care team	Integrated health care team	-

Primary Outcome Measures

Name	Time	Method
Death, non-fatal MI, non-fatal stroke, recurrent angina, emergency room (ER) visit due to any CV-related diseases or readmission due to any CV-related diseases confirmed by the physicians.	one year

Secondary Outcome Measures

Name	Time	Method
BP, lipid, glucose, EBM drugs and self-care efficacy	one year	1. Blood pressure \< 140/90 mmHg (\< 130/80 mmHg in the diabetics and patients with chronic kidney disease); 2. Hypercholesterolemia：LDL \< 100 mg/dl; 3. Diabetic：HbA1c \< 7%; 4. Smoking cessation rate; 5. Adherence rate of EBM medication including anti-platelet agent, beta-blocker, RAS blocker and lipid-lowering agent.; 6. Efficacy of self care

Trial Locations

Locations (1)

Kaohsiung Medical University Hospital; 🇨🇳 Kaohsiung, Taiwan